Zheng Yabing
Zheng Yabing
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| T-DM1 Combined With CDK4/6 Inhibitor Ribociclib | HER2-positive Advanced Breast Cancer | Enrolling by invitation | Phase 2 | 2024-07-01 | NCT06481956 |